Market revenue in 2020 | USD 157.2 million |
Market revenue in 2027 | USD 295.1 million |
Growth rate | 9.4% (CAGR from 2020 to 2027) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Kits, Instruments |
Key market players worldwide | Grifols SA Ordinary Shares - Class A, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Quotient Sciences, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, MedGenome, Beckman Coulter |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood transfusion diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.22% in 2020. Horizon Databook has segmented the China blood transfusion diagnostics market based on reagents & kits, instruments covering the revenue growth of each sub-segment from 2016 to 2027.
China accounted for the second-largest market share in Asia Pacific and is expected to exhibit the fastest growth during the forecast period. According to National Health Commission data, in China, in 2017, around 4,960 metric tons of blood was collected from 15 million donors as compared to 800 tons of blood collected from 328,000 donors in 1998.
Hence, there has been a consecutive increase in the number of people donating blood in the country for more than 20 years. According to a 2016 Global Status Report on Blood Safety and Availability published in 2017, China is focusing on safe blood donations through implementation of advanced testing tools at blood banks and adoption of safety standards equivalent to those in developed countries.
In China, a multilevel blood early warning and distribution mechanism has been introduced to ensure supply of emergency blood requirements.
Horizon Databook provides a detailed overview of country-level data and insights on the China blood transfusion diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into China blood transfusion diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account